Publication of Cancellation of Entries for Kinds of Medical Devices from the Australian Register of Therapeutic Goods – DBS Australia Pty Ltd - 195902

Overview

The Therapeutic Goods Amendment (2013 Measures) Act 2013, enacted in 2013, aims to address discrepancies in the registration and classification of therapeutic goods within Australia, ensuring they meet safety and efficacy standards. This Act was introduced by the Australian Parliament with the policy objective of enhancing the regulation and oversight of therapeutic goods to protect public health. One of the key provisions of this legislation is the authority granted to the delegate of the Secretary to the Department of Health and Ageing to publish details of the cancellation of entries for kinds of medical devices from the Australian Register of Therapeutic Goods when the certification provided is deemed incorrect. This mechanism ensures that only those medical devices which meet the necessary classifications and standards are available for use within Australia, thereby safeguarding consumer safety and maintaining the integrity of the therapeutic goods market.

Scope and Application

The Therapeutic Goods Act 1989 applies to all medical devices, therapeutic goods, and related activities within Australia. Specifically, Section 41GP, under which the cancellation of entries from the Australian Register of Therapeutic Goods is authorised, affects entities that manufacture, supply, or sponsor medical devices in Australia. This includes corporations, businesses, and individuals involved in the distribution or use of medical devices within the country. The geographic reach of this Act is national, applying across all states and territories of Australia. The Act does not explicitly state exclusions or thresholds, but the process of cancellation applies to entries that do not meet the regulatory standards or where the certification is incorrect. The application of the Act can be extended or restricted through subordinate instruments, which may provide further details or criteria for specific types of medical devices or therapeutic goods. This ensures that the Act can adapt to new developments in medical technology and regulatory requirements.

Key Provisions

The legislation in question, specifically section 41GP of the Therapeutic Goods Act 1989, pertains to the cancellation of entries for certain kinds of medical devices from the Australian Register of Therapeutic Goods (ARTG). In this instance, the cancellation involves a skin abrasion unit, identified by the ARTG number 195902, manufactured by Mariotti & C Sri (Italy) and sponsored by DBS Australia Pty Ltd. The cancellation took effect on 31 May 2013 following its publication on 11 April 2013. This action was taken because the certification provided in the application to include this kind of device in the Register was deemed incorrect regarding the classification of the device. Under the Act, the delegate of the Secretary to the Department of Health and Ageing has the authority to publish the cancellation of entries for medical devices from the ARTG when there is a determination that the certification in the application is incorrect. The obligations imposed on the entities involved include ensuring that all certifications provided in applications for the inclusion of medical devices in the ARTG are accurate and comply with the classification criteria. Any discrepancies or inaccuracies must be rectified to prevent the risk of improper devices entering the market, which could pose health risks to consumers. In cases where the requirements of the Act are not met, there are potential civil and criminal consequences for the parties involved. For example, inaccurate certification can lead to the cancellation of the ARTG entry, as seen in this case. Additionally, if it is found that a party has intentionally provided false information, they could face criminal charges. The Act does not specify the maximum penalties for these breaches; however, under general provisions of the Therapeutic Goods Act 1989, penalties for providing misleading or false information can include substantial fines and, in severe cases, imprisonment. The specific penalties would be determined based on the nature and extent of the breach.